X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (189) 189
Publication (16) 16
Book Chapter (4) 4
Book Review (2) 2
Magazine Article (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
conivaptan (142) 142
hyponatremia (113) 113
humans (96) 96
index medicus (80) 80
vasopressin (73) 73
antidiuretic hormone receptor antagonists (63) 63
hyponatremia - drug therapy (61) 61
tolvaptan (61) 61
benzazepines - therapeutic use (53) 53
male (43) 43
heart failure (40) 40
pharmacology & pharmacy (37) 37
female (36) 36
conivaptan hydrochloride (33) 33
benzazepines - administration & dosage (31) 31
drug therapy (27) 27
aged (26) 26
medicine & public health (26) 26
middle aged (26) 26
vasopressin receptor antagonist (26) 26
sodium - blood (25) 25
antidiuretic-hormone (24) 24
double-blind (24) 24
heart failure - drug therapy (24) 24
hyponatremia - etiology (24) 24
hypervolemic hyponatremia (23) 23
hyponatremia - physiopathology (22) 22
arginine vasopressin (21) 21
benzazepines - adverse effects (21) 21
congestive heart failure (21) 21
efficacy (21) 21
intravenous conivaptan (21) 21
treatment outcome (21) 21
animals (20) 20
cardiac & cardiovascular systems (20) 20
placebo-controlled trial (20) 20
siadh (20) 20
urology & nephrology (20) 20
heart-failure (19) 19
medicine, general & internal (19) 19
serum sodium (19) 19
adult (18) 18
care and treatment (18) 18
inappropriate secretion (18) 18
serum sodium concentration (18) 18
v-2-receptor antagonist (18) 18
dosage and administration (17) 17
vaptans (17) 17
ym087 (17) 17
hyponatremia - blood (16) 16
management (16) 16
oral tolvaptan (16) 16
health aspects (15) 15
hyponatremia - diagnosis (15) 15
internal medicine (15) 15
safety (15) 15
sodium (15) 15
antagonist (14) 14
arginine-vasopressin (14) 14
benzazepines - pharmacology (14) 14
clinical neurology (14) 14
dose-response relationship, drug (14) 14
inappropriate adh syndrome - drug therapy (14) 14
lixivaptan (14) 14
vasopressin antagonists (14) 14
controlled-trial (13) 13
heart failure - physiopathology (13) 13
hyponatremia - therapy (13) 13
oral conivaptan (13) 13
pharmacological profile (13) 13
pituitary hormones (13) 13
rats (13) 13
research (13) 13
v-1a (13) 13
vasopressin-receptor antagonist (13) 13
heart failure - complications (12) 12
hypertonic saline (12) 12
long-term treatment (12) 12
multicenter (12) 12
trial (12) 12
vasopressin receptor antagonists (12) 12
aged, 80 and over (11) 11
benzamides - therapeutic use (11) 11
cardiology (11) 11
congestive-heart-failure (11) 11
critical care medicine (11) 11
diagnosis (11) 11
left-ventricular dysfunction (11) 11
pyrroles (11) 11
review (11) 11
inappropriate adh syndrome - complications (10) 10
nephrology (10) 10
retrospective studies (10) 10
worsening heart-failure (10) 10
anti-diuretic hormone (9) 9
clinical trials as topic (9) 9
hyponatremia - complications (9) 9
in-vitro (9) 9
infusions, intravenous (9) 9
injections, intravenous (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


08/2007
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents... 
Heart failure, Candisartan, Spironolactone, Conivaptan, Nesiritide, Omapatrilat
Web Resource
CURRENT ANALYTICAL CHEMISTRY, ISSN 1573-4110, 2019, Volume 15, Issue 5, pp. 591 - 598
Background: Conivaptan inhibits two of vasopressin receptor (vasopressin receptor V1a and V2). Conivaptan is used for the treatment of hyponatremia, and in... 
HYPERVOLEMIC HYPONATREMIA | CHEMISTRY, ANALYTICAL | INTRAVENOUS CONIVAPTAN | UV detection | EFFICACY | mouse plasma | SAFETY | HEART-FAILURE | Conivaptan | vasopressin receptor | pharmacokinetic | HPLC
Journal Article
The American journal of medicine, ISSN 0002-9343, 10/2011, Volume 124, Issue 10, pp. 977.e1 - 977.e9
Journal Article
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, ISSN 1555-9041, 11/2006, Volume 1, Issue 6, pp. 1154 - 1160
The effects of satavaptan (SR121463B), a novel long-acting orally active vasopressin V-2-receptor antagonist, were investigated in patients with the syndrome... 
CONIVAPTAN | MULTICENTER | VPA-985 | CIRRHOSIS | TOLVAPTAN | UROLOGY & NEPHROLOGY | PLACEBO-CONTROLLED TRIAL | V-2 RECEPTOR ANTAGONIST
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 09/2018, Volume 7, Issue 9, p. 262
Changes in serum sodium concentration ([Na+](serum)) can permit evaluation of the treatment effect of vasopressin antagonists (vaptans) in patients with... 
heart failure | biomarkers | TOLVAPTAN | drug evaluation | WORSENING HEART-FAILURE | VASOPRESSIN-RECEPTOR ANTAGONIST | MEDICINE, GENERAL & INTERNAL | INTRAVENOUS CONIVAPTAN | ascites | hyponatremia | SERUM SODIUM CONCENTRATIONS | V-2-RECEPTOR ANTAGONIST | ORAL CONIVAPTAN | PLACEBO-CONTROLLED TRIAL | SUBGROUP ANALYSIS | LONG-TERM TREATMENT
Journal Article
Journal Article
Indian Journal of Critical Care Medicine, ISSN 0972-5229, 12/2016, Volume 20, Issue 12, pp. 714 - 718
Hyponatremia is one of the most common electrolyte abnormalities encountered in clinical practice and has a significant impact on morbidity and mortality in... 
Conivaptan | syndrome of inappropriate antidiuretic hormone | hypertonic saline | hyponatremia | Medical research | Hospital patients | Hyponatremia | Mortality | Medicine, Experimental | Electrolytes | Health aspects | Vasopressin | Complications and side effects | Care and treatment | Dosage and administration | Research | Conivaptan hydrochloride
Journal Article
Journal Article
EUROPEAN NEUROLOGY, ISSN 0014-3022, 2013, Volume 70, Issue 3-4, pp. 142 - 148
Journal Article
American Journal of Therapeutics, ISSN 1075-2765, 2018, Volume 25, Issue 1, pp. e67 - e72
Background: Hyponatremia is frequently encountered in geriatric patients and is associated with significant morbidity and mortality. Traditional management... 
geriatrics | vaptans | hyponatremia | FEMORAL BONE-DENSITY | POLYCYSTIC KIDNEY-DISEASE | NHANES-III | HEART-FAILURE | TOLVAPTAN | HYPERNATREMIA | PREVALENCE | CONIVAPTAN | PHARMACOLOGY & PHARMACY | DEMECLOCYCLINE | SERUM SODIUM CONCENTRATION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.